We recently demonstrated that persistent release of IL-1ab from inflammatory skin causes weight loss, vascular sclerotic changes, and severe systemic amyloidosis in multiple organs. We addressed this question by using skin inflammatory mouse model, keratin-14 driven caspase-1 transgenic mice (KCASP1Tg). In inflammatory diseases such as rheumatoid arthritis, secondary intestinal amyloidosis occurs which causes malabsorption and bowel movement obstruction. Also in KCASP1Tg mice, long-lasting expression of IL-1β causes gastrointestinal amyloidosis. Usually, gastrointestinal amyloidosis is irreversible in many cases and early treatment of primary disease is most important for prevention it. Here, we investigated which anti cytokine antibody is effect for prevention of gastrointestinal amyloidosis.
Article info
Identification
Copyright
© 2019 Published by Elsevier Inc.
User license
Elsevier user license | How you can reuse 
Elsevier's open access license policy
Elsevier user license
Permitted
For non-commercial purposes:
- Read, print & download
- Text & data mine
- Translate the article
Not Permitted
- Reuse portions or extracts from the article in other works
- Redistribute or republish the final article
- Sell or re-use for commercial purposes
Elsevier's open access license policy
